Today, the CEO of Cel-Sci Corp (CVM), Geert Kersten, bought shares of CVM for $24.99K.
Following Geert Kersten’s last CVM Buy transaction on June 13, 2018, the stock climbed by 4.1%.
See today’s analyst top recommended stocks >>
The Company has a Price to Book ratio of 205.3492. The company has a one-year high of $9.93 and a one-year low of $2.37. Currently, Cel-Sci Corp has an average volume of 723.80K.
The insider sentiment on Cel-Sci Corp has been negative according to 28 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS).
